By Sophora Editorial · Evidence reviewed · Published July 2026 · Last reviewed July 2026
Your headaches have changed. Not just more frequent, but different in quality, arriving at different points in your cycle, sometimes building in a way you did not used to experience.
If you have always had migraines, they are probably worse now than they have been since your 20s.
If you have not had migraines before, you may be getting something that feels very different from your usual headache. You are in your 40s, and this is not coincidence.
Migraine is common in midlife, and for some women it becomes more frequent or troublesome during perimenopause.
Hormonal fluctuation is an important part of the explanation, especially for people whose migraine has previously tracked with menstruation, but it is not the only possible cause of a new or changing headache pattern.
Sleep disruption, stress, medicines, blood pressure, other headache disorders, and neurological or systemic illness can also matter. The treatment plan should match the headache diagnosis, not simply the person’s age and hormone stage.
Someone important to you needs this too.
WhatsAppiMessageCopy LinkEmail
Why perimenopause worsens headaches and migraines
Estrogen interacts with several systems involved in migraine, including serotonin signalling, the trigeminovascular system, and calcitonin gene-related peptide, better known as CGRP.
The trigeminovascular system is a network involving the trigeminal nerve and pain-sensitive tissues around the brain; CGRP is one of the signalling molecules involved in migraine attacks. The biology is more complicated than “estrogen prevents migraine” or “CGRP causes blood vessels to dilate and therefore causes pain.”
Migraine is a neurological disorder involving altered sensory processing and multiple interacting pathways.
One influential explanation is the estrogen-withdrawal hypothesis: in hormonally sensitive migraine, a fall in estrogen from a higher level may help trigger an attack.
This fits the timing of many menstrual migraines, which occur around the fall in estrogen before menstruation. The hypothesis has decades of supporting research, although modern reviews also point out that the evidence is not complete and that migraine biology cannot be reduced to one hormone drop.
Hormones may move the migraine threshold; they are not the entire migraine story.
During perimenopause, ovarian hormone patterns become more variable rather than declining in a smooth straight line. For someone whose migraine is sensitive to hormonal change, that variability may mean attacks become less predictable or more frequent.
A previously reliable menstrual pattern can become harder to see when the cycle itself stops behaving like a well-managed diary. Migraine can also begin for the first time in midlife, but a new or substantially changed headache pattern should be medically assessed rather than automatically labelled hormonal.
Progesterone and its neuroactive metabolite allopregnanolone also interact with GABA-A receptors, part of the brain’s inhibitory signalling system. Researchers are studying how these pathways may influence migraine susceptibility, but the clinical evidence is less settled than the evidence linking migraine to estrogen fluctuation.
It is therefore more accurate to describe progesterone as a possible contributor than as a proven second mechanism acting independently of estrogen.
Sleep disruption can make migraine harder to manage and is a commonly reported trigger. Night sweats and hot flushes can disturb sleep, creating an indirect route by which menopause symptoms may worsen migraine burden.
Claims that hot flushes directly trigger migraine through a single shared thermosensitive pathway are more certain than the evidence allows.
Someone important to you needs this too.
WhatsAppiMessageCopy LinkEmail
Types of headache in perimenopause
Menstrual and perimenstrual migraine
Migraine occurring in the two days before menstruation through to the third day of bleeding, driven by premenstrual estrogen withdrawal. In perimenopause, irregular cycles make these attacks less predictable.
They tend to be longer, more severe, and less responsive to standard treatments than non-hormonal migraines.
New-onset migraine in perimenopause
Migraine can begin for the first time during midlife, but a new severe or changing headache deserves assessment. Hormonal fluctuation may contribute, yet the diagnosis should be based on the headache features and clinical history rather than assumed from age alone.
Tension-type headache worsened by hormonal change
Tension-type headache is usually described as pressing or tightening rather than throbbing, often on both sides of the head. Sleep problems, stress, and muscle tension may contribute to headache burden in midlife, but a worsening tension-type headache should not automatically be attributed to hormonal lowering of the pain threshold.
Headache from medication overuse
Frequent use of acute headache medicines can contribute to medication-overuse headache. The threshold depends on the medicine: triptans, opioids, and combination analgesics are generally associated with a 10-days-per-month threshold, while simple analgesics and NSAIDs are generally associated with 15 days per month, when overuse continues for more than three months. The answer is not necessarily to hunt for a hormonal cause; it is to review the diagnosis, acute treatment, and whether preventive treatment is needed.
Important: migraine with aura and stroke risk
Migraine with aura is associated with an increased risk of ischaemic stroke. Combined hormonal contraception is generally contraindicated in people with migraine with aura because estrogen-containing contraception can add vascular risk.
Menopausal hormone therapy is a different clinical question: migraine with aura is not, by itself, an automatic contraindication to HRT. When HRT is appropriate, guidance commonly favours the lowest effective estrogen dose and a transdermal route, such as a patch or gel, because it provides steadier levels and has a different vascular-risk profile from combined hormonal contraception.
The individual discussion should include aura pattern and other stroke risk factors such as smoking, hypertension, and age.
What actually helps
Treat the acute attack effectively
Menstrual migraine attacks are often longer and more disabling than attacks at other times. Acute treatment may include a triptan, an NSAID, or a combination of a triptan with an NSAID when appropriate.
The best choice depends on medical history, cardiovascular risk, other medicines, pregnancy possibility, and previous response. Triptans are migraine-specific medicines that act on serotonin receptors and related trigeminal pathways.
Treatment is generally more effective when taken early in the headache phase, but people with aura are usually advised to take the triptan when headache begins rather than during the aura itself.
Short-term hormonal prevention
For people with predictable menstrual migraine that does not respond adequately to standard acute treatment, short-term prevention may be considered.
Guidelines and specialist practice use selected long-acting triptans or NSAIDs around the expected menstrual window; the exact medicine, timing, and dose require clinical guidance, and some regimens are off-label.
Perimenstrual estrogen supplementation has also been studied, but results are mixed and delayed attacks can occur when supplementation stops. Mini-prevention is much harder to time when perimenopause makes cycles irregular.
Stabilising estrogen with HRT
If HRT is being considered for troublesome menopause symptoms, migraine history should shape the regimen. Transdermal estrogen is often preferred because it produces steadier blood levels than oral estrogen and may be less likely to aggravate hormonally sensitive migraine.
HRT does not reliably eliminate hormonal fluctuation, is not prescribed solely as a standard migraine treatment, and can improve, worsen, or leave migraine unchanged. The aim is the lowest effective dose for menopause symptoms with a regimen suited to the individual’s uterus, bleeding pattern, migraine pattern, and vascular risk.
Conventional prevention for frequent migraine
Frequent or disabling migraine may need preventive treatment whether or not hormones are involved. Options can include medicines such as propranolol, topiramate, amitriptyline, candesartan, CGRP-targeting treatments, and other therapies depending on local guidance and eligibility.
These treatments have different contraindications, pregnancy implications, interactions, and monitoring needs. A primary-care clinician can often begin the assessment and treatment pathway, with neurology or headache-specialist input when the diagnosis is uncertain or migraine remains difficult to control.
Lifestyle factors that reduce migraine threshold
Sleep disruption, missed meals, dehydration, alcohol, and changes in caffeine intake are reported triggers for some people, although triggers vary and should not become an exhausting list of things to fear.
Regular sleep where possible, regular meals, adequate hydration, and a consistent caffeine pattern can help. A headache diary is often more useful than trying to live a perfectly trigger-free life, which is fortunate because the human nervous system has never respected a spreadsheet.
“Hormonal fluctuation can lower the threshold for migraine in susceptible people, but treatment is broader than hormones alone. The useful goal is to reduce attack frequency and disability with a plan that fits your migraine pattern, your menopause symptoms, and your health history.”
When to seek support
See a doctor promptly if:
- You are having frequent headache days, attacks are increasing, or you may need preventive treatment
- Headaches are significantly affecting your daily life or work
- You are using pain relief more than 10 to 15 days per month
- You have migraine with aura and have not discussed the stroke risk implications
- A headache is the worst you have ever had, comes on suddenly, or is accompanied by fever, stiff neck, confusion, or weakness
- Your headache picture has changed significantly and you have not had it assessed
Use Sophora’s The Answers You Need before your appointment. It turns four quiet questions into a doctor-ready summary so you can bring your headache frequency, duration, associated symptoms, medicines used, cycle timing, and whether aura is present to the appointment. This information can materially change the clinical conversation, particularly when discussing prevention, contraception, or HRT.
Questions you are probably asking
Why are my migraines worse in perimenopause?
For some people, migraine becomes more troublesome during perimenopause because ovarian hormone patterns become more variable and falling estrogen can act as a trigger in hormonally sensitive migraine.
Sleep disruption, stress, medication use, and other individual triggers can add to the burden. The pattern varies: some people worsen, some notice little change, and some improve. A diary linking headache days, migraine features, medicines, sleep, and cycle timing can reveal more than guessing from one difficult month.
Will migraines stop after menopause?
Migraine often improves after natural menopause, particularly migraine without aura that has been strongly linked to menstruation, but improvement is not guaranteed and attacks do not always stop completely.
Migraine with aura may follow a different pattern. The transition through perimenopause can be a difficult period for hormonally sensitive migraine, while the more stable hormonal environment after natural menopause helps some people substantially.
Can HRT make migraines worse?
It can. HRT may improve, worsen, or have no effect on migraine. When HRT is needed for menopause symptoms, transdermal estrogen is often preferred in people with migraine because it provides steadier hormone levels than oral estrogen.
Dose matters too: more estrogen is not automatically better, and excessive doses can aggravate headache or aura in some people. The regimen should be reviewed if migraine changes after starting or adjusting HRT.
I have never had migraines. Could these new severe headaches be migraines?
Yes, migraine can begin in midlife, but a new severe headache should be assessed rather than assumed to be perimenopause.
Migraine without aura commonly lasts 4 to 72 hours when untreated or unsuccessfully treated and may involve throbbing pain, pain on one side, worsening with routine activity, nausea, or sensitivity to light and sound. A clinician can assess whether the pattern fits migraine and whether any investigation is needed.
In summary
You now know: Migraine can become more troublesome during perimenopause, particularly in people who are sensitive to hormonal fluctuation. Falling estrogen is an important trigger model, while sleep disruption and other individual factors can add to the burden. A new or substantially changed headache pattern still deserves assessment rather than an automatic hormonal label.
One thing to do: Track headache days, migraine features, medicines used, and cycle timing. A repeated menstrual pattern can help guide treatment, but it does not automatically mean hormonal treatment is the best first option. Standard migraine treatment and short-term prevention may still be appropriate.
Hold onto this: Migraine with aura changes the contraception conversation because combined hormonal contraception is generally contraindicated. HRT is different and is not automatically ruled out, but route, dose, aura pattern, and other vascular risk factors should be discussed explicitly.
Your headache pattern deserves to be understood clearly
Sophora connects your headache picture to your hormonal picture so the right conversation happens.
The Symptom Decoder inside Sophora shows how your headache frequency and picture connect to your cycle and your wider hormonal picture. The Answers You Need gives you the language to raise migraine with aura, the estrogen withdrawal picture, and the transdermal HRT option in your appointment.
Private. Account-bound. Never sold, never used for advertising, never used to train public AI models.
One payment. Twelve months. No subscription.
You’re Not Alone Anymore. Meet Sophora. Your Menopause Companion
A changing headache pattern in midlife can have a hormonal component, but it still deserves a proper diagnosis. Once the pattern is clear, treatment can be matched to the migraine, the menopause symptoms, and the person living with both.
References
- Raffaelli B, et al. Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence. J Headache Pain. 2023;24:131.
- Waliszewska-Prosół M, et al. Menopause, perimenopause, and migraine: understanding the intersections and implications for treatment. 2025.
- Sacco S, et al. Acute and preventive management of migraine during menstruation and menopause. J Clin Med. 2021;10(11):2263.
- International Headache Society. Global practice recommendations for the acute pharmacological treatment of migraine and preventive treatment of migraine. 2024.
- National Institute for Health and Care Excellence (NICE). Headaches in over 12s: diagnosis and management. CG150. Current guidance.
- British Association for the Study of Headache (BASH). National Headache Management System for Adults. Current guidance.
- Australasian Menopause Society. Migraine headaches, menopause and MHT/HRT. Clinical information sheet.
- The Migraine Trust. Migraine and menopause; Menstrual migraine. Current patient guidance.
Last reviewed: July 2026 · Review due: October 2026 · Not therapy. Not medical advice. For your own use and understanding only. · mysophora.com